The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria
Open accessAbstract
Large neutral amino acids (LNAAs), including phenylalanine (Phe), compete for transport across the blood-brain barrier (BBB) via the L-type amino acid carrier. Accordingly, elevated plasma Phe impairs brain uptake of other LNAAs in patients with phenylketonuria (PKU). Direct effects of elevated brain Phe and depleted LNAAs are probably major causes for disturbed brain development and function in PKU. Competition for the carrier might conversely be put to use to lower Phe influx when the plasma concentrations of all other LNAAs are increased. This hypothesis was tested by measuring brain Phe in patients with PKU by quantitative 1H magnetic resonance spectroscopy during an oral Phe challenge with and without additional supplementation with all other LNAAs. Baseline plasma Phe was approximately 1,000 micromol/l and brain Phe was approximately 250 micromol/l in both series. Without LNAA supplementation, brain Phe increased to approximately 400 micromol/l after the oral Phe load. Electroencephalogram (EEG) spectral analysis revealed acutely disturbed brain activity. With concurrent LNAA supplementation, Phe influx was completely blocked and there was no slowing of EEG activity. These results are relevant for further characterization of the LNAA carrier and of the pathophysiology underlying brain dysfunction in PKU and for treatment of patients with PKU, as brain function might be improved by continued LNAA supplementation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinetics of Neutral Amino Acid Transport Across the Blood‐Brain Barrier
Smith, Q. R., Momma, S., Aoyagi, M., & Rapoport, S. I. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb01039.x · Cited by 454
Guldberg, P., Rey, F., Zschocke, J., Romano, V., François, B., Michiels, L., Ullrich, K., Hoffmann, G. F., Burgard, P., Schmidt, H., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301920 · Cited by 353
Kinetic analysis of blood-brain barrier transport of amino acids
Pardridge, W. M., & Oldendorf, W. H. (1975) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(75)90347-8 · Cited by 314
Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids
Pardridge, W. M. (1998) · Neurochemical Research · doi:10.1023/a:1022482604276 · Cited by 281
Neuropsychology of Early-treated Phenylketonuria: Specific Executive Function Deficits
Welsh, M. C., Pennington, B. F., Ozonoff, S. J., Rouse, B. M., & McCabe, E. R. B. (1990) · Child Development · doi:10.1111/j.1467-8624.1990.tb03560.x · Cited by 277
Neutral amino acid transport at the human blood-brain barrier.
Hargreaves, K. M., & Pardridge, W. M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77645-5 · Cited by 199
Krause, W., Halminski, M., McDonald, L., et al. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111695 · Cited by 194
Neuropsychology of Early-Treated Phenylketonuria: Specific Executive Function Deficits
Welsh, M. C., Pennington, B. F., Ozonoff, S., Rouse, B., & McCabe, E. R. B. (1990) · Child Development · doi:10.2307/1130832 · Cited by 181
Versatile frequency domain fitting using time domain models and prior knowledge
Slotboom, J., Boesch, C., & Kreis, R. (1998) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910390607 · Cited by 167
Self-citationONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY
Gunn, J., Reynolds, E. H., Chadwick, D., & Galbraith, A. W. (1976) · The Lancet · doi:10.1016/s0140-6736(76)92881-6 · Cited by 167
Quantitative localized 1H MR spectroscopy for clinical use
Kreis, R. (1997) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/s0079-6565(97)00014-9 · Cited by 166
Self-citationOlsen, R. W., & DeLorey, T. M. (1999) · Cited by 129
1 H NMR Studies of Glucose Transport in the Human Brain
Rolf Gruetter, A., Novotny, E. J., Boulware, S. D., Rothman, D. L., & Shulman, R. G. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199605000-00009 · Cited by 106
Early-treated phenylketonuria: Adult neuropsychologic outcome
Ris, M. D., Williams, S. E., Hunt, M. M., Berry, H. K., & Leslie, N. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70360-4 · Cited by 105
Pietz, J., Kreis, R., SCHMIDT, H. C., et al. (1996) · Radiology · doi:10.1148/radiology.201.2.8888233 · Cited by 101
Self-citationKinetic Constants for Blood—Brain Barrier Amino Acid Transport in Conscious Rats
Miller, L. P., Pardridge, W. M., Braun, L. D., & Oldendorf, W. H. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07209.x · Cited by 101
Phenylketonuria: Biochemical Mechanisms
Kaufman, S. (1977) · Springer eBooks · doi:10.1007/978-1-4615-8237-3_1 · Cited by 101
Novotny, E. J., Avison, M. J., HERSCHKOWITZ, N. N., et al. (1995) · Pediatric Research · doi:10.1203/00006450-199502000-00020 · Cited by 68
Pietz, J., Schmidt, E., Matthis, P., Kobialka, B., Kutscha, A., & de Sonneville, L. M. J. (1993) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1993.tb11552.x · Cited by 63
Self-citationKreis, R., Pietz, J., Penzien, J. M., HERSCHKOWITZ, N. N., & Boesch, C. (1995) · Journal of Magnetic Resonance Series B · doi:10.1006/jmrb.1995.1084 · Cited by 62
Self-citationInhibition of Neutral Amino Acid Transport Across the Human Blood‐Brain Barrier by Phenylalanine
Shulkin, B. L., Betz, A. L., Koeppe, R. A., & Agranoff, B. W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64031252.x · Cited by 59
Knudsen, G. M., Hasselbalch, S. G., Toft, P. B., Christensen, E., Paulson, O. B., & LOU, H. C. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf02436753 · Cited by 57
Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria
Pietz, J., Landwehr, R., Kutscha, A., Schmidt, H., de Sonneville, L. M. J., & Trefz, F. K. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70031-5 · Cited by 56
Self-citationPhenylalanine Transport at the Human Blood-Brain Barrier
Pardridge, W. M. (1988) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4615-9821-3_5 · Cited by 55
Krause, W. L., Epstein, C. M., Averbook, A., Dembure, P. P., & Elsas, L. J. (1986) · Pediatric Research · doi:10.1203/00006450-198611000-00010 · Cited by 52
Berry, H. K., Bofinger, M. K., Hunt, M. M., Phillips, P. J., & Guilfoile, M. B. (1982) · Pediatric Research · doi:10.1203/00006450-198209000-00009 · Cited by 45
Asymmetrical Transport of Amino Acids across the Blood—Brain Barrier in Humans
Knudsen, G. M., Pettigrew, K. D., Patlak, C. S., Hertz, M. M., & Paulson, O. B. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.123 · Cited by 44
Valine, Isoleucine, and Leucine: A New Treatment for Phenylketonuria
Berry, H. K. (1990) · American journal of diseases of children · doi:10.1001/archpedi.1990.02150290033020 · Cited by 44
Esterman, A. L., Dancis, J., Lee, J. D., & Rindler, M. J. (1995) · Pediatric Research · doi:10.1203/00006450-199507000-00001 · Cited by 39
LOU, H. C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90250-8 · Cited by 36
Transport inhibition in the pathology of phenylketonuria and other inherited metabolic diseases
PRATT, O. E. (1982) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01805567 · Cited by 33
Hommes, F. A. (1988) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01805529 · Cited by 22
Nutritional value of essential amino acids in the treatment of adults with phenylketonuria
Dotremont, H., François, B., Diels, M., & Gillis, P. (1995) · Journal of Inherited Metabolic Disease · doi:10.1007/bf00711746 · Cited by 18
Cited by
Blau, N., van Spronsen, F. J., & Levy, H. L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60961-0 · Cited by 1,086
The complete European guidelines on phenylketonuria: diagnosis and treatment
van Wegberg, A. M. J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A. M., Burlina, A., Campistol, J., Feillet, F., Giżewska, M., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-017-0685-2 · Cited by 830
Phenylalanine hydroxylase deficiency
Mitchell, J. J., Trakadis, Y. J., & Scriver, C. R. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182141b48 · Cited by 536
Branched-Chain Amino Acids and Brain Function
Fernstrom, J. D. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1539s · Cited by 514
van Spronsen, F. J., Blau, N., Harding, C., Burlina, A., Longo, N., & Bosch, A. M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00267-0 · Cited by 497
Metadata
- Authors
- Pietz, J., Kreis, R., Rupp, A., Mayatepek, E., Rating, D., Boesch, C., & Bremer, H. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-04-15
- Volume
- 103
- Issue
- 8
- Pages
- 1169-1178
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2052438797
- Cited by
- 300
- References
- 33
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.